FY2025 · ended Dec 31, 2025 · Revenue $780.99M, +16.3% YoY · Filed Feb 27, 2026
U S Physical Therapy Inc /NV (USPH) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $781.0 million and net income of $39.6 million. Free cash flow was $61.0 million. As of Sep 30, 2026 it held $38.2 million in cash and investments and $419.9 million in total debt.
Revenue (TTM)
$837.63M
+10.4% vs year-ago TTM
Net income (TTM)
$30.13M
-32.5% vs year-ago TTM
Operating cash flow (TTM)
$88.83M
+27.8% vs year-ago TTM
Free cash flow (TTM)
$69.10M
+21.4% vs year-ago TTM
EPS (TTM)
$2.00
-32.2% vs year-ago TTM
Dividend per share (TTM)
$1.83
+2.2% vs year-ago TTM
Shares outstanding
15.12M
-0.5% vs prior year
Net cash
$-381.71M
as of Sep 30, 2026
Operating margin
9.1%
FY 2026
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- USPH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Houston, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 885978
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M |
| Operating income | $86.7M | $63.0M | $50.5M | $56.8M | $70.6M |
| Net income | $39.6M | $31.4M | $28.2M | $32.2M | $40.8M |
| Diluted EPS | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| Operating cash flow | $75.1M | $74.9M | $82.0M | $58.5M | $76.4M |
| Free cash flow | $61.0M | $65.8M | $72.7M | $50.3M | $68.2M |
| Total assets | $1.2B | $1.2B | $997.2M | $858.2M | $749.4M |
| Total liabilities | $433.8M | $408.4M | $345.0M | $373.6M | $297.0M |
| Stockholders' equity | $476.4M | $488.9M | $476.2M | $315.8M | $295.6M |
| Cash and investments | $35.6M | $41.4M | $152.8M | $31.6M | $28.6M |
| Total debt | $315.2M | $295.2M | $258.6M | $295.3M | $223.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 28, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 14, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2026 | Aug 6, 2026 |
All 1001 U S Physical Therapy Inc /NV SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.